Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)-Reference-Cited by-同舟云学术

Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)

Published:2021-10-01 Issue:10 Volume:7 Page:1476
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Siva Shankar¹²,Bressel Mathias³,Mai Tao⁴,Le Hien⁵,Vinod Shalini⁶,de Silva Harini⁷,Macdonald Sean⁷,Skala Marketa⁸,Hardcastle Nicholas⁹,Rezo Angela¹⁰,Pryor David⁴,Gill Suki¹¹,Higgs Braden⁵,Wagenfuehr Kassandra¹²,Montgomery Rebecca¹²,Awad Raef⁸,Chesson Brent¹³,Eade Thomas¹⁴,Wong Wenchang¹⁵,Sasso Giuseppe¹⁶,De Abreu Lourenco Richard¹⁷,Kron Tomas²⁴,Ball David¹²,Neeson Paul²⁷,Bettington Catherine¹⁸,Cook Olivia¹⁸,Foote Matthew¹⁸,Gowda Raghu¹⁸,Haas Marion¹⁸,Haynes Nicole M¹⁸,Hilder Bronwyn¹⁸,Lao Louis¹⁸,Lim Adeline¹⁸,Ludbrook Jane¹⁸,Jansen Therease¹⁸,MacManus Michael¹⁸,McCullough Susan A¹⁸,Moore Alisha¹⁸,Ritchie David¹⁸,Shaw Mark¹⁸,Sia Joseph¹⁸,Syed Farhan¹⁸,Tang Colin¹⁸,Trapani Joseph¹⁸,

Affiliation:

1. Department of Radiation Oncology, Peter MacCallum Cancer Centre, Victoria, Australia

2. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia

3. Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Victoria, Australia

4. Radiation Oncology Centre, Princess Alexandra Hospital, Queensland, Australia

5. Department of Radiation Oncology, Royal Adelaide Hospital, South Australia, Australia

6. Cancer Therapy Centre, Liverpool Hospital, New South Wales, Australia

7. Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

8. Royal Hobart Hospital, Tasmania, Australia

9. Department of Physical Sciences, Peter MacCallum Cancer Centre, Victoria, Australia

10. Canberra Hospital, Garran, Australian Capital Territory, Australia

11. Sir Charles Gairdner Hospital, Western Australia, Australia

12. Trans Tasman Radiation Oncology Group (TROG) Cancer Research, New South Wales, Australia

13. Department of Radiation Therapy, Peter MacCallum Cancer Centre, Victoria, Australia

14. Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia

15. Department of Radiation Oncology, Prince of Wales Hospital, New South Wales, Australia

16. Radiation Oncology Department, Auckland City Hospital, New Zealand

17. Centre for Health Economics Research and Evaluation, University of Technology Sydney, New South Wales, Australia

18. for the Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung (SAFRON) II Study Investigators

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2783660/jamaoncology_siva_2021_oi_210047_1634002268.88567.pdf

Reference21 articles.

1. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial.;Iyengar;JAMA Oncol,2018

2. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase ii randomized trial.;Palma;J Clin Oncol,2020

3. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase ii, randomized study.;Gomez;J Clin Oncol,2019

4. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.;Siva;J Thorac Oncol,2010

5. Long-term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer.;Videtic;Int J Radiat Oncol Biol Phys,2019

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET;BMC Cancer;2024-02-03

2. Radiotherapy in the management of lung oligometastases;Cancer/Radiothérapie;2024-02

3. Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy;Cancer/Radiothérapie;2024-02

4. Stereotactic body radiotherapy for early-stage lung cancer: a systematic review on the choice of photon energy and linac flattened/unflattened beams;Radiation Oncology;2024-01-02

5. Palliative radiotherapy in oligometastases;Palliative Radiation Oncology;2024